Ornicon Pharma Private Limited
About Ornicon Pharma Private Limited
Data last updated:
Ornicon Pharma Private Limited is a private limited company based in Mangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 March 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2010PTC052841. Its GSTIN is 29AABCO2592B1ZK (Karnataka).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Parvathi Manoj Shastry and Manoj Narasimha Shastry.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. T – 7 D – No – 4 – 93/72 3rd Floor Padil Commercial Center, Shanthi Nagar Mangalore Bangalore Highway, Karnataka, India – 575007.
As per the financials filed for FY 2025, the company reported a revenue of ₹35.04 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹1.54 Lakh (net margin 4.4%) and EBITDA of ₹1.86 Lakh (EBITDA margin 5.3%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 5% over five years.
As per MCA filings, the company has satisfied charges of ₹18 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ornicon Pharma Private Limited's registered office is in Mangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo. T – 7 D – No – 4 – 93/72 3rd Floor Padil Commercial Center, Shanthi Nagar Mangalore Bangalore Highway, Karnataka, India – 575007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ornicon Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ornicon Pharma is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Ornicon Pharma Private Limited, buy the company report.
Financials of Ornicon Pharma Private Limited
FY 2025 filings availableOrnicon Pharma Private Limited reported revenue of ₹35.04 Lakh (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 9% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA rose 288% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.86 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 4.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ornicon Pharma Private Limited, buy the company report.
Board of directors of Ornicon Pharma Private Limited
Ornicon Pharma has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parvathi Manoj Shastry | Director | 08 Feb 2019 | 7 Years 8 Months | Current |
| Manoj Narasimha Shastry | Director | 07 Jan 2019 | 7 Years 9 Months | Current |
Auditor
Ornicon Pharma Private Limited is audited by RAO & BASRI for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAO & BASRI | FY 2017 | 005523S |
Shareholding
The shareholding of Ornicon Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ornicon Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Sep 2017 | 100131033 | Canara Bank | ₹15 Lakh | Satisfied | |
| 17 Mar 2015 | 10558396 | Canara Bank | ₹3 Lakh | Satisfied |
To see the full charge records of Ornicon Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Ornicon Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ornicon Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ornicon Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCO2592B1ZK | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ornicon Pharma Private Limited, buy the company report.
Recent activity
Ornicon Pharma Private Limited has 9 board changes on record since 2015: 2 appointments and 7 cessations. The latest: Parvathi Manoj Shastry ceased to be Additional Director on 30 Sep 2019.
4 earlier events are in the company report.
Frequently asked questions
Ornicon Pharma is an active private limited company based in Mangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 March 2010 (16+ years old) and is registered under CIN U51909KA2010PTC052841.
Ornicon Pharma has 2 current directors:
- Parvathi Manoj Shastry - Director
- Manoj Narasimha Shastry - Director
The latest financial statements of Ornicon Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ornicon Pharma is 29AABCO2592B1ZK, registered in Karnataka.
The CIN (Corporate Identification Number) of Ornicon Pharma is U51909KA2010PTC052841. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ornicon Pharma was incorporated on 12 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Bangalore.
Parvathi Manoj Shastry ceased to be Additional Director on 30 Sep 2019. Parvathi Manoj Shastry was appointed as Director on 08 Feb 2019. Anil Kumar Mundodi ceased to be Managing Director on 07 Jan 2019. Ornicon Pharma has 9 board changes on record in total.
The registered office of Ornicon Pharma is at No. T – 7 D – No – 4 – 9372 3rd Floor Padil Commercial Center, Shanthi Nagar Mangalore Bangalore Highway, Karnataka, India – 575007.
Ornicon Pharma operates in the pharma industry, in the drug formulation and development segment.
Ornicon Pharma has no open charges and satisfied charges of ₹18 Lakh as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
